Abstract | BACKGROUND: We have reported that pretreatment with KB-R9032, a newly developed Na+ -H+ exchange inhibitor is protective against reperfusion-induced ventricular arrhythmia in the isolated perfused rat heart. This study was conducted to elucidate whether the drug is equally effective when it is given at the time of reperfusion. METHODS: Male Wistar rat hearts (n=32, 16 for each group) were perfused by means of Langendorff technique. Each heart was subjected to regional ischemia (occlusion of the left anterior descending coronary artery for 11 minutes) and to three minutes of reperfusion (release of the occlusion). KB-R9032 4 mg (one shot group) or a vehicle without drug (control) were given 30 seconds before the reperfusion to 30 seconds after the reperfusion. RESULTS: In the control group reperfusion-induced ventricular fibrillation (VF) occurred in 91.7% and the duration was 165 +/- 14.4 seconds, but, in one shot group, the incidence of VF decreased to 6.3% and the duration of VF was reduced to 0.4 +/- 0.4 seconds, respectively (P<0.05 vs control group). CONCLUSIONS: It has been shown in this study that the Na+/H+ exchange inhibitor KB-R9032 given at the time of reperfusion suppresses reperfusion arrhythmias in the ischemia-reperfusion model of isolated rat heart.
|
Authors | Minoru Ono, Masato Nakamura, Yoshihisa Koga |
Journal | Masui. The Japanese journal of anesthesiology
(Masui)
Vol. 53
Issue 9
Pg. 982-8
(Sep 2004)
ISSN: 0021-4892 [Print] Japan |
PMID | 15500096
(Publication Type: Journal Article)
|
Chemical References |
- Guanidines
- N-(4-isopropyl-2,2-dimethyl-3-oxo-3,4-dihydro-2H-benzo(1,4)oxazine-6-carbonyl)guanidine
- Oxazines
- Sodium-Hydrogen Exchangers
|
Topics |
- Animals
- Arrhythmias, Cardiac
(prevention & control)
- Disease Models, Animal
- Guanidines
(administration & dosage, pharmacology)
- In Vitro Techniques
- Male
- Myocardial Reperfusion Injury
(prevention & control)
- Oxazines
(administration & dosage, pharmacology)
- Rats
- Rats, Wistar
- Sodium-Hydrogen Exchangers
(antagonists & inhibitors)
|